YUHYLYX
LIVE

Serial Number

79273535

Owner

Yuyu Pharma, Inc.

Attorney

Richard Y. Kim

Filing Date

Oct 7, 2019

Add to watchlist:

No watchlists yet
View on USPTO

YUHYLYX Trademark

Serial Number: 79273535 • Registration: 6192057

YUHYLYX is a trademark filed by Yuyu Pharma, Inc. on October 7, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Yuyu Pharma, Inc. (15 trademarks)

Chungcheongbuk-do , KR

Entity Type: 03

Trademark Details

Filing Date

October 7, 2019

Registration Date

November 10, 2020

Published for Opposition

August 25, 2020

Goods & Services

Androgen preparations; pharmaceutical agents affecting metabolism; pharmaceutical preparations for treatment of erectile dysfunction and benign prostate hyperplasia; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparations for inducing erections; pharmaceutical preparations for treatment of conditions affecting urogenital organs; pharmaceutical preparations for prevention of sexual dysfunction; pharmaceutical preparations for the treatment of sexual dysfunction; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for treatment of benign prostate hyperplasia; drugs for medical purposes, pharmaceutical drugs and medicines for human purposes, namely, pharmaceutical preparations for the treatment and prevention of ophthalmic, dermatological, urological, hematological, bone, skeletal, respiratory, endocrinological, circulatory, gastroenterological, hormonal, diabetic, muscular, rheumatic, immune system, ocular, psychiatric, cognitive, mood, infectious, oncological, gynecological, sexual, and pediatric disorders; hormones for medical purposes; pharmaceutical drugs in the nature of pharmaceutical preparations used for the treatment of Alopecia, Androgenetic Alopecia, and Alopecia Areata; pharmaceutical preparations for treatment of premature ejaculation; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations for treatment of conditions affecting respiratory organs

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 10, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 14, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 24, 2021 FICS
FINAL DISPOSITION PROCESSED
Feb 23, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 10, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 10, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 25, 2020 NPUB
PUBLISHED FOR OPPOSITION
Aug 25, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 5, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 22, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 22, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 22, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 22, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 22, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 7, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 6, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 6, 2020 TROA
REFUSAL PROCESSED BY IB
Feb 28, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 10, 2020 RFCS
REFUSAL PROCESSED BY MPU
Feb 10, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 18, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jan 17, 2020 CNRT
ASSIGNED TO EXAMINER
Jan 10, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 14, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 10, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 5, 2019 REPR